Consultation Draft - Requirements for Haemopoietic Cellular Therapy (seventh edition)
The Commission is seeking feedback on the draft Requirements for Haemopoietic Cellular Therapy (HCT Standard) which aims to protect the public from harm and support delivery of high-quality cellular therapy programs. It describes a consistent framework that cellular therapy program facilities must meet to be eligible for Medicare rebates.
The updated draft requirements are intended to support Australian HCT programs to:
- align with international best practice
- include safety rules for new cellular therapies
- set clear expectations for good governance, patient-centred care, safe systems, and respectful, inclusive communication that supports patients in making decisions about their care.
Downloads
Consultation Draft - Requirements for Haemopoietic Cellular Therapy (seventh edition)
- For more information:
- Requirements for Haemopoietic Cellular Therapy
- Publication Year:
- 2026
- Resource Type:
- Publication or report
Accessibility: We aim to provide documents in an accessible format. If you're having problems using a document with your accessibility tools, please contact us for help.
Copyright: Unless stated otherwise, materials provided are covered by a Creative Commons Attribution-Non-Commercial-No Derivatives (BY-NC-ND) 4.0 International License.
Request permission to reproduce material produced by the Commission by completing this form.